[ chat ]
Thanks, guys/gal. I'm happiest for the scientists and managers at RGEN. They've worked hard to bring a company back from textbook crummy management. They inherited a mess and took the steps necessary to clean up, and they're pretty straight-shooters......
RGEN 3 +1 33/64 3 9/16 1 33/64 37221 +104.2%
I *don't* mean to imply that they're significantly undervalued at this market cap. They are very, very early-stage (but supported by sales from a process-related reagent, and somewhat "safe" for a bio). I thought they were a screaming buy a year ago at $1, and I think that they have real potential from this point forward. However, I wouldn't be wading in tomorrow unless you're very nimble and slightly crazy, even relative to Ray.
:-)
I sold PGEN today and kept SUGN and RGEN. If there's any justice, IMO, some money should float from ENMD toward SUGN and other later-stage efforts.
I thought that biotech had a stronger day than this......
FBIOX 32.72 +0.34 +1.0%
FKGHX 19.19 +0.05 +0.2%
BTK 176.97 +2.03 177.44 174.94 +1.1%
.INDU 9,192.66 +45.59 9,261.91 9,145.33 +0.4%
.IXB 333.89 +4.73 334.32 331.15 +1.4%
Not bad, but I thought that it was even better.
Again, NEPF..... thanks for taking the time, late last night, to pull us all together.
Cheers! Rick |
